FDA
approval
· 2019-12-18
FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
Summary
FDA approved a supplemental application for the amlodipine besylate and atorvastatin calcium combination product, submitted by Prasco Laboratories. This approva…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for AMLODIPINE AND ATORVASTATIN (AMLODIPINE AND ATORVASTATIN)